Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancer

Radical cystectomy (RC) is still considered standard of treatment for patients with non-metastatic muscle-invasive bladder cancer (MIBC) and high-risk non-muscle-invasive bladder cancer (NMIBC) refractory to intravesical therapy in most countries [1]. However, RC has significant morbidity and mortality [2].

Source: Radiotherapy and Oncology - October 16, 2019 Category: Radiology Authors: Charlotte S. Voskuilen, Judith Bosschieter, Erik van Werkhoven, Kees Hendricksen, Andr é N. Vis, Thelma Witteveen, Bradley R. Pieters, Max Burger, Axel Bex, Henk G. van der Poel, Luc M. Moonen, Simon Horenblas, Jakko A. Nieuwenhuijzen, Bas W.G. van Rhijn Tags: Original Article Source Type: research